CompletedPhase 4NCT05247866

Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis

Studying NON RARE IN EUROPE: Eosinophilic esophagitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Philadelphia
Principal Investigator
Jonathan Spergel, MD, PhD
Children's Hospital of Philadelphia
Intervention
Eosinophilic Esophagitis (EoE) food introduction-1st(dietary_supplement)
Enrollment
21 enrolled
Eligibility
6-25 years · All sexes
Timeline
20222025

Study locations (1)

Collaborators

Regeneron Pharmaceuticals · Genzyme, a Sanofi Company

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05247866 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Eosinophilic esophagitis

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis

← Back to all trials